INDRAMEDCO Stock Overview
Indraprastha Medical Corporation Limited provides hospital services in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Indraprastha Medical Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹245.20 |
| 52 Week High | ₹254.00 |
| 52 Week Low | ₹81.90 |
| Beta | 0.74 |
| 1 Month Change | 39.04% |
| 3 Month Change | 45.35% |
| 1 Year Change | 184.29% |
| 3 Year Change | 306.30% |
| 5 Year Change | 534.41% |
| Change since IPO | 2,579.78% |
Recent News & Updates
Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06
Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Recent updates
Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21Shareholder Returns
| INDRAMEDCO | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 8.8% | -3.7% | -1.6% |
| 1Y | 184.3% | 62.3% | 45.0% |
Return vs Industry: INDRAMEDCO exceeded the Indian Healthcare industry which returned 62.3% over the past year.
Return vs Market: INDRAMEDCO exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| INDRAMEDCO volatility | |
|---|---|
| INDRAMEDCO Average Weekly Movement | 8.2% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: INDRAMEDCO's share price has been volatile over the past 3 months.
Volatility Over Time: INDRAMEDCO's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 2,947 | Shivakumar Pattabhiraman | www.delhi.apollohospitals.com |
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, endovascular surgery, endocrinology, ENT, fetal medicine, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, ophthalmology, pediatric sciences, urology, and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neurology/neurosurgery, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, sleep medicine and clinical care, and transfusion medicine. The company was founded in 1983 and is based in New Delhi, India.
Indraprastha Medical Corporation Limited Fundamentals Summary
| INDRAMEDCO fundamental statistics | |
|---|---|
| Market cap | ₹22.48b |
| Earnings (TTM) | ₹1.13b |
| Revenue (TTM) | ₹12.04b |
20.0x
P/E Ratio1.9x
P/S RatioIs INDRAMEDCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INDRAMEDCO income statement (TTM) | |
|---|---|
| Revenue | ₹12.04b |
| Cost of Revenue | ₹5.15b |
| Gross Profit | ₹6.89b |
| Other Expenses | ₹5.77b |
| Earnings | ₹1.13b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.29 |
| Gross Margin | 57.24% |
| Net Profit Margin | 9.35% |
| Debt/Equity Ratio | 1.1% |
How did INDRAMEDCO perform over the long term?
See historical performance and comparison